Blood melatonin level can serve as a potential biomarker for prostate and hepatocellular carcinomas

Many systemic functions display circadian rhythms driven by an endogenous mechanism that is regulated by circadian-related genes and these gene expressions control a central clock in the brain and subordinate clocks in peripheral tissues. However, modern life has introduced environmental factors that often interfere with natural circadian rhythms. Importantly, circadian disruption has been identified as an independent risk factor of cancers.

Blood melatonin level can serve as a potential biomarker for prostate and hepatocellular carcinomas Read More »